Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder

Neuropsychobiology

Volumn 69, Issue 4, 2014, Pages 235-242

  Ahmadpanah, Mohammad ^a   Sabzeiee, Parasto ^a   Hosseini, Seyed Mohammad ^a   Torabian, Saadat ^b   Haghighi, Mohammad ^a   Jahangard, Leila ^a   Bajoghli, Hafez ^c   Holsboer Trachsler, Edith ^d   Brand, Serge ^d,e  

^a HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF BASEL   (Switzerland)

^e UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Hydroxyzine; Pittsburgh Sleep Quality Index; Placebo; Posttraumatic stress disorder; Prazosin; Sleep quality

Indexed keywords

ALPRAZOLAM; CLONAZEPAM; HYDROXYZINE; LORAZEPAM; PLACEBO; PRAZOSIN; SERTRALINE; CENTRAL NERVOUS SYSTEM AGENTS;

ADULT; ARTICLE; BEDTIME DOSAGE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG SAFETY; EVENING DOSAGE; FEMALE; GASTROINTESTINAL DISEASE; GROUP DYNAMICS; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; PITTSBURGH SLEEP QUALITY INDEX; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RANDOMIZED CONTROLLED TRIAL; SLEEP QUALITY; SLEEP TIME; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; XEROSTOMIA; COMPARATIVE STUDY; DREAM; DRUG EFFECTS; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGIC TEST; SLEEP; SLEEP DISORDERS; STRESS DISORDERS, POST-TRAUMATIC; NAUSEA; NIGHTMARE;

ADULT; CENTRAL NERVOUS SYSTEM AGENTS; DREAMS; FEMALE; HUMANS; HYDROXYZINE; INTERVIEW, PSYCHOLOGICAL; MALE; NEUROPSYCHOLOGICAL TESTS; PRAZOSIN; SLEEP; SLEEP DISORDERS; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME;

EID: 84923181110     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000362243     Document Type: Article

References (34)

1. Cirelli C, Tononi G, Pompeiano M, Pompeiano O, Gennari A: Anxiety disorders: posttraumatic stress disorder; in Diagnostic and Statistical Manual of Mental Disorders (DSMIV), ed 4. Washington, American Psychiatric Association, 1994, pp 424-429.
2. National Center for Post Traumatic Stress Disorder: What is PTSD? www. ncptsd.va. gov/ncmain/ncdocs/fact-shts/fs-faqs-on- ptsd.html (accessed Jan 10, 2012).
3. Van Liempt S, Vermetten E, Geuze E, Westenberg HGM: Pharmacotherapy for disordered sleep in posttraumatic stress disorder: a systematic review. Int Clin Psychopharmacol 2006; 21: 193-202.
4. Schoenfeld FB, Deviva JC, Manber R: Treatment of sleep disturbances in posttraumatic stress disorder: a review. J Rehabil Res Dev 2012; 49: 729-752.
5. Sjostrom NI, Hetta J, Waern M: Persistent nightmares are associated with repeat suicide attempt: a prospective study. Psychiatry Res 2009; 170: 208-211.
6. Tanskanen A, Tuomilehto J, Viinamaki H, Vartiainen E, Lehtonen J, Puska P: Nightmares as predictors of suicide. Sleep 2001; 24: 844-847.
7. Southwick SM, Krystal JH, Morgan CA, Johnson D, Nagy LM, Nicolaou A, et al: Abnormal noradrenergic function in posttraumatic stress disorder. Arch Gen Psychiatry 1993; 50: 266-274.
8. Schnurr PP, Friedman MJ, Bernardy NC: Research on posttraumatic stress disorder: epidemiology, pathophysiology, and assessment. J Clin Psychol 2002; 58: 877-889.
9. Daly CM, Doyle ME, Radkind M, Raskind E, Daniels C: Clinical case series: the use of prazosin for combat-related recurrent nightmares among Operation Iraqi Freedom combat veterans. Mil Med 2005; 170: 513-515.
10. Taylor FT, Raskind MA: The 1 -adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder. J Clin Psychopharmacol 2002; 22: 82-85.
11. Boehnlein JKI, Kinzie JD: Pharmacologic reduction of CNS noradrenergic activity in PTSD: the case for clonidine and prazosin. J Psychiatr Pract 2007; 13: 72-78.
12. Menkes DB, Baraban JM, Aghajanian GK: Prazosin selectively antagonizes neuronal responses mediated by 1 -adrenoceptors in brain. Naunyn Schmiedebergs Arch Pharmacol 1981; 317: 273-275.
13. Taylor FB, Martin P, Thompson C, Williams J, Mellman TA, Gross C, Raskind MA: Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma PTSD: a placebo-controlled study. Biol Psychiatry 2008; 63: 629-632.
14. Kung S, Espinel Z, Lapid MI: Treatment of nightmares with prazosin: a systematic review. Mayo Clin Proc 2012; 87: 890-900.
15. Raskind MA, Peskind ER, Hoff DJ, Hart KL, Holmes HA, Warren D, et al: A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbances in combat veterans with posttraumatic stress disorder. Biol Psychiatry 2007; 61: 928-934.
16. Peskind ER, Bonner LT, Hoff DJ, et al: Prazosin reduces trauma-related nightmares in older men with chronic post-traumatic stress disorder. J Geriatr Psychiatry Neurol 2003; 16: 165-171.
17. Guaiana GI, Barbui C, Cipriani A: Hydroxyzine for generalised anxiety disorder. Cochrane Database Syst Rev 2010; 12:CD006815.
18. Linden M, Bandelow B, Boerner RJ, Brasser M, Kasper S, Moller HJ, Pyrkosch L, Volz HP, Wittchen HU: The best next drug in the course of generalized anxiety disorders: the 'PN-GAD-algorithm'. Int J Psychiatry Clin Pract 2013; 17: 78-89.
19. Kubo N, Shirakawa O, Kuno T, Tanaka C: Antimuscarinic effects of antihistamines: quantitative evaluation by receptor-binding assay. Jpn J Pharmacol 1987; 43: 277-282.
20. Barranco SF, Bridger W: Treatment of anxiety with oral hydroxyzine: an overview. Curr Ther Res 1977; 22: 217-227.
21. Rothbaum BO, Stein, DJ, Hollander E: Textbook of Anxiety Disorders. Washington, American Psychiatric Publishing, 2009.
22. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4, text rev (DSMIV-TR). Washington, American Psychiatric Association, 2000.
23. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ: The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193-213.
24. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59(suppl 20):22-33.
25. Asadollahi GH, Ahmadzadeh GH, Mahmmudi- Gharaie J, Bashar Dost N, Faghihi T: The effect of prazosin on war post-traumatic stress disorders. Iran J Psychiatry 2003; 8: 1-4.
26. Berger W, Mendlowicz MV, Marques-Portella C, Kinrys G, Fontenelle LF, Marmar CR, et al: Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 169-180.
27. Escamilla M, LaVoy M, Moore BA, Krakow B: Management of post-traumatic nightmares: a review of pharmacologic and nonpharmacologic treatments since 2010. Curr Psychiatry Rep 2012; 14: 529-535.
28. Germain A, Richardson R, Moul DE, Mammen O, Haas G, Forman SD, et al: Placebocontrolled comparison of prazosin and cognitive- behavioral treatments for sleep disturbances in US Military Veterans. J Psychosom Res 2012; 72: 89-96.
29. Narimani M, Zahed A, Basharpoor S: Prevalence of posttraumatic stress disorder in hospital emergency nurses and fire department workers in Uremia city. Behav Sci Res 2010; 8: 69-74.
30. Lee B, Youm Y: Social network effects on post-traumatic stress disorder (PTSD) in female North Korean immigrants. J Prev Med Public Health 2011; 44: 191-200.
31. Fakour Y, Mahmoudi-gharaei J, Mohammadi MR, Karimi M, Azar M, Momtaz-bakhsh M: The effect of psychosocial supportive Interventions on PTSD symptoms after Bam earthquake. Tehran Univ Med J 2006; 64: 55-64.
32. Magruder KM, Frueh BC, Knapp RG, Johnson MR, Vaughan JA 3rd, Carson TC, et al: PTSD symptoms, demographic characteristics, and functional status among veterans treated in VA primary care clinics. J Trauma Stress 2004; 17: 293-301.
33. Fetzner MG, Abrams MP, Asmundson GJ: Symptoms of posttraumatic stress disorder and depression in relation to alcohol-use and alcohol-related problems among Canadian forces veterans. Can J Psychiatry 2013; 58: 417-425.
34. Campbell DG, Felker BL, Liu CF, Yano EM, Kirchner JE, Chan D, et al: Prevalence of depression- PTSD comorbidity: implications for clinical practice guidelines and primary carebased interventions. J Gen Intern Med 2007; 22: 711-718.